If you are considering GLP-1 therapy for weight loss, we offer a free initial consultation to see if our program is right for you.
Application Context: BPC-157 is studied in vitro for its potential effects on: Angiogenesis and endothelial cell growth Cellular migration and tissue regeneration Muscle, tendon, and ligament recovery models Inflammatory modulation and oxidative stress pathways Cytoprotective and gastroprotective mechanisms Intended Use: This product is intended exclusively for in vitro research use
Medical history and medication review to flag any interactions or contraindications before prescribing Goal-specific protocol selection based on injury location, duration, and severity rather than a one-size-fits-all 500 mcg recommendation Written reconstitution and injection instructions with the exact mL and unit markings for the patients specific vial and prescribed dose Injection training for self-administration patients, either in-clinic or via telehealth video walkthrough Week-four check-in to assess response, adjust dose or frequency if needed, and confirm the patient is completing the cycle correctly Pharmacy-grade 503A product with verified purity, sterility, and potency from an FDA-registered compounding pharmacy For patients who have never injected a peptide before, we also review the BPC-157 benefits and mechanism in detail before starting the protocol so the patient understands what the peptide does, what to expect during the cycle, and what results realistically look like at four, eight, and twelve weeks
Some products were only tested chemically and were not tested for sterility or endotoxins
When youre losing weight rapidly, roughly 25 percent of the loss can come from lean tissue if you dont train
Expected timeline and results Patients taking semaglutide injection start seeing changes in their weight within the first few weeks of starting once-weekly semaglutide, losing up to 10.9% of their weight within 6 months
